1 |
Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC: Cellular Dysfunction in the Diabetic Fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 162: 303, 2003
DOI
ScienceOn
|
2 |
De Loecker W, Koptelov VA, Grischenko VI, De Loecker P: Effects of cell concentration on viability and metabolic activity during cryopreservation. Cryobiology 37: 103, 1998
DOI
ScienceOn
|
3 |
Kano M, Masuda Y, Tominaga T, Hori T, Kitaichi T, Yoshizumi M, Kitagawa T: Collagen synthesis and collagenase activity of cryopreserved heart valves. J Thorac Cardiovasc Surg 122: 706, 2001
DOI
ScienceOn
|
4 |
Liu K, Yang Y, Mansbridge J: Comparison of the stress response to cryopreservation in monolayer and three-dimensional human fibroblast cultures: stress proteins, MAP kinases, and growth factor gene expression. Tissue Eng 6: 539, 2000
DOI
ScienceOn
|
5 |
Han SK, Choi KJ, Kim WK: Clinical application of fresh fibroblast allografts for the treatment of diabetic foot ulcers: a pilot study. Plast Reconstr Surg 114: 1783, 2004
DOI
ScienceOn
|
6 |
Veves A, Falanga V, Armstrong DG, Sabolinski ML: Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers. Diabetes Care 24: 290, 2001
DOI
ScienceOn
|
7 |
Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH: Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor- BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 7: 335, 1999
DOI
|
8 |
Marston WA, Hanft J, Norwood P, Pollak R: The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care 26: 1701, 2003
DOI
ScienceOn
|
9 |
Pham HT, Rosenblum BL, Lyons TE, Giurini JM, Chrzan JS, Habershaw GM, Veves A: Evaluation of a human skin equivalent for the treatment of diabetic foot ulcers in a prospective, randomized, clinical trial. Wounds 11: 79, 1999
|
10 |
Hehenberger K, Heilborn JD, Brismar K, Hansson A: Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound Repair Regen 6: 135, 1998
DOI
ScienceOn
|
11 |
Mansbridge JN, Liu K, Pinney RE, Patch R, Ratcliffe A, Naughton GK: Growth factors secreted by fibroblasts: role in healing diabetic foot ulcers. Diabetes Obes Metab 1: 265, 1999
DOI
ScienceOn
|
12 |
Sams HH, Chen J, King LE: Graftskin treatment of difficult to heal diabetic foot ulcers: one center's experience. Dermatol Surg 28: 698, 2002
DOI
ScienceOn
|
13 |
Mansbridge JN, Liu K, Pinney RE, Patch R, Ratcliffe A, Naughton GK: Growth factors secreted by fibroblasts: role inhealingdiabetic foot ulcers. Diabetes Obes Metab 1: 265, 1999
DOI
ScienceOn
|